Metastatic Cancer Treatment Market Trends

LIST OF TABLES
1 Total Regional Geriatric Population by Region
(%), 2015 and 2030
2 Impact of Market Drivers
3 Impact of Market Restraints
4 Market Share (2014-2017)
5 Estimated New Cases and Estimated Deaths in
2018 as per American Cancer Society
6 GLOBOCAN Data as of 2012
7 Common sites of Metastasis for Cancers
8 Common Classes of Drugs Under Different
Cancer Therapies
9 Recent FDA Approvals of Oncology Drugs
10 Impact of Market Drivers
11 Impact of Market Restraints
12 Comparison of R&D Expense 2017 and 2016
13 Recent Approval of Metastatic Cancer Drugs
14 Side Effects Caused by common Metastatic
Cancer Drugs
15 Regulatory Scenario Across the World
16 Regulatory Designations Across The World
17 Patent Landscape
18 Factors Affecting the Bargaining Power of
Suppliers
19 Factors Affecting the Bargaining Power of Buyer
20 Factors Affecting Threat of New Entrant
21 Factors Affecting the Threat of Substitute
22 Factors Affecting the Intensity of Competitive
Rivalry
23 Market Share of Key Players (2014-2017)
24 Pipeline Analysis of Metastatic Cancer Treatment
Drugs
25 Estimated Incidence, Mortality, and Prevalence of
Breast Cancer Worldwide in 2012
26 Estimated Incidence and Mortality of Melanoma
Worldwide in 2012
27 Estimated Incidence, Mortality and Prevalence of
Prostate Cancer Worldwide in 2012
28 Estimated Incidence, Mortality and Prevalence of
Lung Cancer (for both sexes) Worldwide in 2012
29 Estimated Incidence, Mortality and Prevalence of
Colorectal Cancer (for both sexes) Worldwide in
2012
30 Estimated Incidence, Mortality and Prevalence of
Different Cancer (for both sexes) Worldwide in
2012
31 List of Companies and Drugs for Various
Therapeutic Indication
32 List of Common Brand-name Drugs used to treat
Metastatic Cancer
33 List of Common Generic Drugs used to treat
Metastatic Cancer
34 Sales of Oncology Drugs
35 State-wise distribution of Cancer in India
36 List of Tier 1 and Tier 2 Companies
37 AbbVie Inc.: Recent Developments
38 Amgen, Inc.: Recent Developments
39 AstraZeneca PLC: Recent Developments
40 Bayer AG: Recent Developments
41 Boehringer Ingelheim International GmbH:
Recent Developments
42 BRISTOL-MYERS SQUIBB COMPANY: Recent
Developments
43 CELGENE CORPORATION: Recent Developments
44 Eli-Lilly and Company: Recent Developments
45 F. Hoffmann-La Roche AG: Recent Developments
46 JOHNSON & JOHNSON: Recent Developments
47 Merck & Co.,Inc. : Recent Developments
48 Novartis AG: Recent Developments
49 Pfizer, Inc.: Recent Developments
50 SANOFI: Recent Developments
51 Takeda Pharmaceutical Company Limited: Recent
Developments
sales@bisresearch.com www.bisresearch.com 3